SCHEMBL4649629

SCHEMBL4649629

Brc1ccc2nc(N3CCNC[C@H]3C(CCc3ccccc3)C3CCCNC3)ncc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.36
CYP3A4 P08684 6/20 0.36
HTR2C P28335 4/20 0.36
HTR2B P41595 3/20 0.36
CYP2D6 P10635 5/20 0.34
SLC6A4 P31645 4/20 0.34
SLC6A2 P23975 3/20 0.34
SLC6A3 Q01959 3/20 0.34
PDE6D O43924 2/20 0.34
HTR2A P28223 1/20 0.33
ALDH1A1 P00352 5/20 0.33
CYP2C9 P11712 4/20 0.33
HSD17B10 Q99714 4/20 0.33
CASP1 P29466 4/20 0.33
CASP7 P55210 4/20 0.33
USP2 O75604 4/20 0.33
CYP2C19 P33261 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650542 0.77 HTR2C (0.37) HTR2CHTR2BCYP2D6SLC6A4SLC6A2
SCHEMBL4650992 0.71 HTR2C (0.35) HTR2CHTR2BCYP2D6SLC6A4SLC6A2
SCHEMBL1779189 0.71 OGA (0.38) ALDH1A1HSD17B10KMT2ATSHRKIT
SCHEMBL14495610 0.64 CCR2 (0.45) SLC6A4SLC6A2SLC6A3CASP1MEN1
SCHEMBL1779188 0.64 CCR2 (0.45) SLC6A4SLC6A2SLC6A3CASP1MEN1
SCHEMBL1779190 0.61 OGA (0.40) MEN1KMT2A
SCHEMBL23199603 0.60 HTR3A (0.51) ALDH1A1TSHRMAPK1SMN1; SMN2CLK4
SCHEMBL30718597 0.60 HTR3A (0.51) ALDH1A1TSHRMAPK1SMN1; SMN2CLK4
SCHEMBL26775614 0.60 HTR3A (0.51) ALDH1A1TSHRMAPK1SMN1; SMN2CLK4
SCHEMBL1778793 0.60 KDM4E (0.41) CYP1A2CYP3A4HTR2CSLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966187-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071952-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2007-06-28 WO disclosed